These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 31812624)
1. 21-Benzylidene digoxin decreases proliferation by inhibiting the EGFR/ERK signaling pathway and induces apoptosis in HeLa cells. Pessôa MTC; Valadares JMM; Rocha SC; Silva SC; McDermott JP; Sánchez G; Varotti FP; Scavone C; Ribeiro RIMA; Villar JAFP; Blanco G; Barbosa LA Steroids; 2020 Mar; 155():108551. PubMed ID: 31812624 [TBL] [Abstract][Full Text] [Related]
2. 21-Benzylidene digoxin: a proapoptotic cardenolide of cancer cells that up-regulates Na,K-ATPase and epithelial tight junctions. Rocha SC; Pessoa MT; Neves LD; Alves SL; Silva LM; Santos HL; Oliveira SM; Taranto AG; Comar M; Gomes IV; Santos FV; Paixão N; Quintas LE; Noël F; Pereira AF; Tessis AC; Gomes NL; Moreira OC; Rincon-Heredia R; Varotti FP; Blanco G; Villar JA; Contreras RG; Barbosa LA PLoS One; 2014; 9(10):e108776. PubMed ID: 25290152 [TBL] [Abstract][Full Text] [Related]
3. Selectivity analyses of γ-benzylidene digoxin derivatives to different Na,K-ATPase α isoforms: a molecular docking approach. Pessôa MTC; Alves SLG; Taranto AG; Villar JAFP; Blanco G; Barbosa LA J Enzyme Inhib Med Chem; 2018 Dec; 33(1):85-97. PubMed ID: 29115894 [TBL] [Abstract][Full Text] [Related]
4. Differences of lipid membrane modulation and oxidative stress by digoxin and 21-benzylidene digoxin. Silva LND; Pessoa MTC; Alves SLG; Venugopal J; Cortes VF; Santos HL; Villar JAFP; Barbosa LA Exp Cell Res; 2017 Oct; 359(1):291-298. PubMed ID: 28720385 [TBL] [Abstract][Full Text] [Related]
5. Alkylamino Phenol Derivative Induces Apoptosis by Inhibiting EGFR Signaling Pathway in Breast Cancer Cells. Palanivel S; Yli-Harja O; Kandhavelu M Anticancer Agents Med Chem; 2020; 20(7):809-819. PubMed ID: 32053080 [TBL] [Abstract][Full Text] [Related]
6. γ-Benzylidene digoxin derivatives synthesis and molecular modeling: Evaluation of anticancer and the Na,K-ATPase activity effect. Alves SLG; Paixão N; Ferreira LGR; Santos FRS; Neves LDR; Oliveira GC; Cortes VF; Salomé KS; Barison A; Santos FV; Cenzi G; Varotti FP; Oliveira SMF; Taranto AG; Comar M; Silva LM; Noël F; Quintas LEM; Barbosa LA; Villar JAFP Bioorg Med Chem; 2015 Aug; 23(15):4397-4404. PubMed ID: 26122772 [TBL] [Abstract][Full Text] [Related]
7. Induction of autophagy enhances apoptotic cell death via epidermal growth factor receptor inhibition by canertinib in cervical cancer cells. Aydinlik S; Dere E; Ulukaya E Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):903-916. PubMed ID: 30825616 [TBL] [Abstract][Full Text] [Related]
8. Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells. Jameson MJ; Beckler AD; Taniguchi LE; Allak A; Vanwagner LB; Lee NG; Thomsen WC; Hubbard MA; Thomas CY Mol Cancer Ther; 2011 Nov; 10(11):2124-34. PubMed ID: 21878657 [TBL] [Abstract][Full Text] [Related]
9. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway. Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811 [TBL] [Abstract][Full Text] [Related]
10. Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI001) with apoptosis-inducing mechanisms in breast cancer. Liu B; Fu L; Zhang C; Zhang L; Zhang Y; Ouyang L; He G; Huang J Oncotarget; 2015 Mar; 6(9):6762-75. PubMed ID: 25742792 [TBL] [Abstract][Full Text] [Related]
11. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer. Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140 [TBL] [Abstract][Full Text] [Related]
12. Combination of sublethal concentrations of epidermal growth factor receptor inhibitor and microtubule stabilizer induces apoptosis of glioblastoma cells. Failly M; Korur S; Egler V; Boulay JL; Lino MM; Imber R; Merlo A Mol Cancer Ther; 2007 Feb; 6(2):773-81. PubMed ID: 17308073 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and anticervical cancer activity of new benzofuran-pyrazol-hydrazono- thiazolidin-4-one hybrids as potential EGFR inhibitors and apoptosis inducing agents. Abbas HS; Abd El-Karim SS Bioorg Chem; 2019 Aug; 89():103035. PubMed ID: 31200286 [TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid shows antineoplastic effects in bile duct cancer cells via apoptosis induction; p53 activation; and EGFR-ERK, COX-2, and PI3K-AKT pathway inhibition. Lee J; Hong EM; Kim JH; Kim JH; Jung JH; Park SW; Koh DH; Jang HJ Mol Biol Rep; 2021 Sep; 48(9):6231-6240. PubMed ID: 34392440 [TBL] [Abstract][Full Text] [Related]
15. Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways. Wei G; Wang M; Carr BI J Cell Physiol; 2010 Jul; 224(1):112-9. PubMed ID: 20301194 [TBL] [Abstract][Full Text] [Related]
16. Characterization of ERK docking domain inhibitors that induce apoptosis by targeting Rsk-1 and caspase-9. Boston SR; Deshmukh R; Strome S; Priyakumar UD; MacKerell AD; Shapiro P BMC Cancer; 2011 Jan; 11():7. PubMed ID: 21219631 [TBL] [Abstract][Full Text] [Related]
17. Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors. Sabbah DA; Hajjo R; Sweidan K Curr Top Med Chem; 2020; 20(10):815-834. PubMed ID: 32124699 [TBL] [Abstract][Full Text] [Related]
18. β,β-Dimethylacrylshikonin induces mitochondria dependent apoptosis through ERK pathway in human gastric cancer SGC-7901 cells. Shen XJ; Wang HB; Ma XQ; Chen JH PLoS One; 2012; 7(7):e41773. PubMed ID: 22848597 [TBL] [Abstract][Full Text] [Related]
19. Lymecycline reverses acquired EGFR-TKI resistance in non-small-cell lung cancer by targeting GRB2. Chen Y; Wu J; Yan H; Cheng Y; Wang Y; Yang Y; Deng M; Che X; Hou K; Qu X; Zou D; Liu Y; Zhang Y; Hu X Pharmacol Res; 2020 Sep; 159():105007. PubMed ID: 32561477 [TBL] [Abstract][Full Text] [Related]
20. Apoptosis is induced in cancer cells via the mitochondrial pathway by the novel xylocydine-derived compound JRS-15. Sun C; Guo XX; Zhu D; Xiao C; Bai X; Li Y; Zhan Z; Li XL; Song ZG; Jin YH Int J Mol Sci; 2013 Jan; 14(1):850-70. PubMed ID: 23344045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]